Join
Live feed
·
INSIDERFilingvia Quantisnow
Ventyx Biosciences Inc. logo

Nuss John sold $8,921 worth of shares (1,651 units at $5.40), decreasing direct ownership by 0.62% to 264,998 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VTYX· Ventyx Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VTYX (Ventyx Biosciences Inc.) and more on Quantisnow.